Cancer immunotherapy may reshape brain’s barrier to metastasis, Pg2

Key Highlights:

• A recent study reveals that PD-1 inhibitors, a common cancer immunotherapy, can increase the permeability of the blood-brain barrier (BBB).
• The compromised BBB may lead to increased brain metastases in some patients treated with anti-PD-1 therapy.
• Researchers identified the protein DKK1 as a key factor in BBB disruption during anti-PD-1 therapy.
• MRI scans of lung cancer patients showed increased cancer spread in the brain linked to higher levels of plasma DKK1 after anti-PD-1 therapy.
• Combining anti-PD-1 therapy with cisplatin chemotherapy improved survival in mice with brain metastases, suggesting a potential double-edged role.

Detailed Insights:

• The blood-brain barrier (BBB) is a tightly regulated interface that protects the brain by restricting the passage of substances from the bloodstream into brain tissue.
• Immunotherapy, particularly immune checkpoint inhibitors (ICIs) like anti-PD-1, has shown promise in treating cancers by activating immune cells to target tumors.
• Responses to ICIs in patients with brain metastases are varied, with some experiencing remission and others rapid disease progression, highlighting the complexity of the brain-immune ecosystem.
• The study found that anti-PD-1 therapy can lead to a loss of cells maintaining blood vessel stability, weaker barrier proteins, and increased immune cell entry into the brain, indicating a compromised BBB.

Metastasis.png

• Elevated levels of DKK1 may indicate a more permissive brain environment for metastasis, potentially explaining varied responses to immunotherapy in patients with brain metastases.
• Opening the BBB with anti-PD-1 therapy could improve the delivery of chemotherapeutic drugs to the brain but may also allow circulating cancer cells to enter, potentially increasing the risk of new metastases.
• Identifying biomarkers like DKK1 could help identify patients at higher risk of developing brain metastases during treatment and guide treatment strategies.

Key Concepts Involved:

• Blood-Brain Barrier (BBB): A protective layer of cells that prevents harmful substances from entering the brain.
• Immunotherapy: Treatment that uses the body's own immune system to fight cancer.
• Metastasis: The spread of cancer cells from the primary tumor to other parts of the body.
• Biomarker: A measurable substance in an organism whose presence is indicative of some phenomenon such as disease, infection, or environmental exposure.